James Investment Research Inc Amgen Inc Transaction History

James Investment Research Inc

$853 Million
Q3 2024

A detailed history of James Investment Research Inc transactions in Amgen Inc stock. As of the latest transaction made, James Investment Research Inc holds 4,109 shares of AMGN stock, worth $1.09 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

4,109

Previous 3,993 2.91%

Holding current value

$1.09 Million

Previous $1.25 Million 6.09%

% of portfolio

0.16%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $35,888 - $39,136	116 Added 2.91%	4,109 $1.32 Million
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $8,408 - $10,217	-32 Reduced 0.8%	3,993 $1.25 Million
Q1 2024 May 01, 2024	SELL	$268.87 - $324.56 $4,301 - $5,192	-16 Reduced 0.4%	4,025 $1.14 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $36,565 - $41,249	-143 Reduced 3.42%	4,041 $1.16 Million
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $21,646 - $26,874	99 Added 2.42%	4,184 $1.12 Million
Q2 2023 Aug 07, 2023	BUY	$214.27 - $253.37 $138,632 - $163,930	647 Added 18.82%	4,085 $906,000
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $159,633 - $194,566	-707 Reduced 17.06%	3,438 $831,000
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $23,819 - $30,265	104 Added 2.57%	4,145 $1.09 Million
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $52,972 - $59,743	236 Added 6.2%	4,041 $911,000
Q2 2022 Aug 01, 2022	BUY	$230.71 - $256.74 $124,121 - $138,126	538 Added 16.47%	3,805 $926,000
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $50,212 - $55,548	229 Added 7.54%	3,267 $790,000
Q4 2021 Jan 28, 2022	SELL	$198.88 - $227.6 $39,776 - $45,520	-200 Reduced 6.18%	3,038 $683,000
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $40,543 - $47,501	-191 Reduced 5.57%	3,238 $689,000
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $31,766 - $35,243	-136 Reduced 3.81%	3,429 $836,000
Q1 2021 Apr 22, 2021	SELL	$221.91 - $258.6 $3.86 Million - $4.5 Million	-17,388 Reduced 82.99%	3,565 $887,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $7.66 Million - $9.12 Million	-35,387 Reduced 62.81%	20,953 $4.82 Million
Q3 2020 Oct 23, 2020	SELL	$234.65 - $260.95 $1.02 Million - $1.14 Million	-4,350 Reduced 7.17%	56,340 $14.3 Million
Q2 2020 Jul 24, 2020	SELL	$197.81 - $242.74 $317,287 - $389,354	-1,604 Reduced 2.57%	60,690 $14.3 Million
Q1 2020 Apr 22, 2020	BUY	$182.24 - $241.7 $520,112 - $689,811	2,854 Added 4.8%	62,294 $12.6 Million
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $359,688 - $462,323	1,901 Added 3.3%	59,440 $14.3 Million
Q3 2019 Oct 30, 2019	SELL	$174.11 - $208.62 $663,359 - $794,842	-3,810 Reduced 6.21%	57,539 $11.1 Million
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $600,120 - $703,476	-3,600 Reduced 5.54%	61,349 $11.3 Million
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $397,190 - $447,720	2,196 Added 3.5%	64,949 $12.3 Million
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $213,009 - $248,650	1,194 Added 1.94%	62,753 $12.2 Million
Q3 2018 Oct 26, 2018	SELL	$185.29 - $208.89 $3.34 Million - $3.76 Million	-18,010 Reduced 22.63%	61,559 $12.8 Million
Q2 2018 Jul 19, 2018	BUY	$166.05 - $186.51 $2.26 Million - $2.54 Million	13,620 Added 20.65%	79,569 $14.7 Million
Q1 2018 Apr 12, 2018	BUY	$169.43 - $198.0 $5.79 Million - $6.77 Million	34,173 Added 107.54%	65,949 $11.2 Million
Q4 2017 Jan 23, 2018	SELL	$168.79 - $188.59 $456,576 - $510,135	-2,705 Reduced 7.84%	31,776 $5.53 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $5.77 Million - $6.59 Million	34,481	34,481 $6.43 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account

James Investment Research Inc Amgen Inc Transaction History